Tarakji Bassel, Nassani Mohammad Z
Department of Oral Pathology, Faculty of Dentistry Aleppo University, Aleppo, Syria.
Kulak Burun Bogaz Ihtis Derg. 2010 May-Jun;20(3):129-36.
This study aims to highlight the current points of view regarding the management of pleomorphic adenomas among oral and maxillofacial surgeons in the United Kingdom.
A questionnaire was drafted and sent to all the consultant members of the British Society of Oral Maxillofacial Surgery (n=263). The survey evaluated the surgical experience of the surgeon, the preferred surgical treatment of a newly diagnosed 3 cm diameter pleomorphic adenoma in the superficial lobe of the parotid gland in an adult and a child, and the treatment options of pleomorphic salivary adenoma (PSA) with the four following scenarios: (i) PSA with complete excision or incomplete excision; (ii) PSA with carcinoma in situ (atypical pleomorphic adenoma) with complete excision or incomplete excision; (iii) PSA with non-invasive malignant transformation with complete or incomplete excision; and (iv) carcinoma in PSA with complete or incomplete excision. The initial response was low so two reminders were sent to increase the rate of response.
The final response rate was 67%. The results showed that there was no significant difference in the opinions of the respondents regarding treatment of pleomorphic adenoma in both adults and children. Seventy-five (56.4%) of 133 surgeons were treated the multinodular recurrence in older patients with surgery combined with radiotherapy. One-hundred and five (78.9%) surgeons were treated older patients with solitary recurrence with surgery alone. There was a consensus on complete excision for the treatment of carcinoma in situ (atypical pleomorphic adenoma) or PSA with non-invasive malignant transformation.
This survey shows that superficial parotidectomy is the standard treatment method for primary pleomorphic adenoma in children and adults. Surgery combined with radiotherapy is the preferred option in the case of multinodular recurrence, and surgery alone is recommended in the case of a solitary recurrence.
本研究旨在强调英国口腔颌面外科医生对多形性腺瘤治疗的当前观点。
起草了一份问卷并发送给英国口腔颌面外科协会的所有顾问成员(共263人)。该调查评估了外科医生的手术经验、成人及儿童腮腺浅叶新诊断出的直径3厘米多形性腺瘤的首选手术治疗方法,以及在以下四种情况下多形性腺瘤(PSA)的治疗选择:(i)PSA完整切除或不完整切除;(ii)原位癌(非典型多形性腺瘤)的PSA完整切除或不完整切除;(iii)非侵袭性恶性转化的PSA完整或不完整切除;(iv)PSA中的癌完整或不完整切除。最初的回复率较低,因此发送了两次提醒以提高回复率。
最终回复率为67%。结果显示,受访者对成人和儿童多形性腺瘤治疗的意见没有显著差异。133名外科医生中有75名(56.4%)采用手术联合放疗治疗老年患者的多结节复发。105名(78.9%)外科医生仅通过手术治疗老年患者的孤立性复发。对于原位癌(非典型多形性腺瘤)或非侵袭性恶性转化的PSA的治疗,完整切除已达成共识。
本次调查表明,浅叶腮腺切除术是儿童和成人原发性多形性腺瘤的标准治疗方法。多结节复发时,手术联合放疗是首选方案;孤立性复发时,建议仅进行手术。